PUBLISHER: Allied Market Research | PRODUCT CODE: 1298462
PUBLISHER: Allied Market Research | PRODUCT CODE: 1298462
The global microbial cellulose market was valued at $20.7 million in 2022, and is projected to reach $64.5 million by 2032, growing at a CAGR of 12.2% from 2023 to 2032.
Microbial cellulose or bacterial cellulose is a natural biomaterial produced by bacteria. Also, microbial cellulose with various morphologies and physiochemical properties can be made by adding nanoparticles, polymers, and other components to the culture media. Consequently, microbial cellulose is a sustainable and highly competitive alternative to plant-based cellulose nanofibers.
Further, microbial cellulose possesses a special structure of cellulose nanofiber-weaved 3D reticulated network. It has superior mechanical properties, exceptional suspension stability, and high water-holding capability. Besides, microbial cellulose has a high degree of crystallinity, high purity, and excellent biocompatibility and biodegradability. Owing to these benefits, microbial cellulose has achieved significant traction in both academic as well as industrial areas such as food, textile, household chemicals, personal care, biomedicine, composite resin, and others.
For the purpose of analysis, the microbial cellulose market scope covers segmentation based on growth medium, application, and region. The report provides information on the growth medium segment including synthetic and natural. Furthermore, the major applications covered in the study include food & beverage, medical, cosmetics & personal care, paper, textile, and others. In addition, it analyzes the current market trends across different regions such as North America, Europe, Asia-Pacific, and LAMEA.
The growth drivers, restraints, and opportunities are explained in the report to better understand the market dynamics. This report further highlights the key areas of investment. In addition, it includes Porter's five forces analysis to understand the competitive scenario of the industry and the role of each stakeholder. Value chain analysis for this industry, which includes R&D, components manufacturers, assembly, programming & testing, marketing & sales, customers, and post-sales services, is explained. The report features the strategies adopted by key market players to maintain their foothold in the market. Furthermore, it highlights the competitive landscape of the key players to increase their market share and sustain the intense competition in the industry.
In addition, the report covers profiles of key industry participants such as Ashland, Axcelon Biopolymers Corporation, BacPolyZyme, BIOESQUE, Borregaard AS, BOWIL Biotech Sp. z o.o., HBBE, HNB BIO CO., LTD, HYSSES, and Merck KGaA.